Objectives: To determine which risk factors contribute to worse COVID-19 outcome in children. Methods: Data sources: The review was conducted in Medline, CINAHL, Pubmed, Scopus, Web of Science, and LILACS. Study selection and data extraction: Articles published in the last year, written in Portuguese, English, and Spanish were included. Duplicates, editorials, letters to the editor, theses, dissertations, review articles, reports, case studies, and studies not addressing the theme were excluded. Controlled terms in Portuguese and English indexed in (DeCS) and (MeSH), and the Boolean operators “AND” and “OR” were used. Synthesis: The risk of bias was calculated using the R software, analysed by the GRADE system and using a funnel plot. All effects were analysed and calculated at a 95% confidence interval. The evidence level was analysed using Stillwell and collaborators’ proposal. Results: A total of 1,628 articles were found. All articles were written in English, one was published in 2019, and 10 in 2020. Six studies were descriptive, two were multicentric cohort studies, two were retrospective cohort studies, one was observational-retrospective, and most were evidence level VI. In essence, all studies pointed out that children with underlying diseases tend to develop more severe COVID-19 illnesses and more hospitalization than children without these diseases. Conclusion: The knowledge of the risk factors related to worse COVID-19 outcomes by professionals allow a better assessment of patients and make them able to act with greater precision in the promotion, prevention, and rehabilitation of these children.

Background: Infection caused by SARS-CoV-2 virus is a recent disease that is easily spread and has serious complications, such as neuropsychiatric signs and symptoms. Thus, studies are necessary on the clinical manifestations during and/or after the course of the disease. Aims and objectives: To describe the relationship between neuropsychiatric signs and symptoms and SARS-CoV-2 infection. Methods: Systematic review conducted in the Pubmed Portal, Brazilian Virtual Health Library, Cochrane, and Science Direct databases. The descriptors coronavirus, SARS, and neurologic symptoms were used in Pubmed, Cochrane, and Science Direct databases, while the descriptors SARS Virus and Nervous System were used in the Virtual Health Library database. A total of 1024 studies were found and 67 were selected to compose this systematic review. The studies were analyzed qualitatively with the narrative description divided into four thematic categories. Results: There is a pathophysiological relationship between SARS-CoV-2 infection and manifestations involving the Central Nervous System and the Peripheral Nervous System through different pathways and mechanisms. The chances of Nervous System manifestations increase in elderly patients with associated morbidities, such as obesity, diabetes mellitus, chronic obstructive pulmonary disease and/or pre-existing neurological/psychiatric diseases. The most cited neuropsychiatric signs and symptoms were headache, delirium, smell and/or taste disorders, and stroke. The evaluation and monitoring of patients during and after COVID-19 infection is important for the early detection and treatment of neuropsychiatric signs and symptoms. Conclusions: It is recommended that health professionals monitor patients with COVID-19 infection or who had recently had the disease for detecting neuropsychiatric signs and symptoms, especially elderly patients, people with comorbidities such as cardiovascular and pulmonary diseases, diabetes mellitus, and obesity, and patients with pre-existing neurological/psychiatric diseases. Decision-making for the implementation of an early rehabilitation treatment can be reinforced in this groups, minimizing the sequels resulting from COVID-19.